4180496/2025-AQ.CENTRAL L492-LINEZOLID 600 MG FILM COATED TABLETS
About This Opportunity
TranslatedThis tender, reference 4180496/2025, concerns the central acquisition (AQ.CENTRAL) of Linezolid 600 mg film-coated tablets, designated under L492. Linezolid is an important antibiotic used to treat serious infections caused by certain types of bacteria, particularly Gram-positive bacteria, including those resistant to other antibiotics like MRSA. The procurement aims to secure a supply of this critical medication for healthcare facilities. The tender will detail the required specifications, including dosage (600 mg), form (film-coated tablets), packaging, quantities, and adherence to pharmaceutical quality standards (e.g., GMP, pharmacopoeia compliance). Bidders must be licensed pharmaceutical suppliers or manufacturers capable of providing authentic Linezolid. Evaluation criteria will prioritize the quality and authenticity of the drug, compliance with all regulatory requirements, delivery reliability, and competitive pricing. This ensures the availability of essential antibiotics for patient treatment.
This is a supplies contract in the health and medical services, trade and industry and general supplies sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 5,463.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified as 4180496/2025-AQ.CENTRAL L492-LINEZOLIDE 600 MG COMP REVEST, is a public procurement opportunity issued within Portugal. The contracting authority, whose specific details are managed through the Portal BASE, is seeking to acquire a supply of Linezolid 600 mg film-coated tablets.
This procurement falls under the category of pharmaceutical supplies, crucial for healthcare services.
The tender is expected to attract bids from pharmaceutical manufacturers and distributors capable of meeting the stringent quality and regulatory standards required for medicinal products. Typical requirements for such tenders include demonstrating compliance with Good Manufacturing Practices (GMP), holding relevant marketing authorizations from national or European regulatory bodies, and providing detailed product specifications, including active pharmaceutical ingredient (API) sourcing and manufacturing processes. Bidders will likely need to submit comprehensive documentation regarding their manufacturing facilities, quality control procedures, and any prior experience in supplying similar pharmaceutical products to public health systems. Furthermore, proposals will be evaluated based on factors such as the quality and efficacy of the proposed product, the supplier's capacity to ensure consistent and timely delivery, and competitive pricing. The contracting authority will be looking for a reliable long-term supply of this essential antibiotic, vital for treating serious bacterial infections.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 12, 2026. Last refreshed 7 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, EPE
Unidade Local de Saúde do Arco Ribeirinho, EPE has issued 360 procurement notices on BidsFactory, including 0 currently open and 333 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LABORATORIOS PFIZER, S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €5,463. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.